Appili was created to deliver innovative drug development programs for unmet patient needs across a broad spectrum of infectious diseases
Advancing DRUG DEVELOPMENT IN infectious disease AND BIODEFENSE to provide solutions to patients, doctors, and society
A novel oral taste-masked suspension of metronidazole to treat serious anaerobic and protozoal infections
A potential first-in-class live-attenuated vaccine for tularemia, a serious biothreat
A novel topical antiparasitic product to treat disfiguring skin infections around the world
EventWashington, DC
View Event
EventToronto, ON
View Event
EventGrnoble Alpes, France
View Event
